Marinomed Biotech AG (VIE:MARI)
Austria flag Austria · Delayed Price · Currency is EUR
19.90
-0.05 (-0.25%)
Oct 3, 2025, 5:35 PM CET

Marinomed Biotech AG Statistics

Total Valuation

VIE:MARI has a market cap or net worth of EUR 36.71 million. The enterprise value is 46.14 million.

Market Cap36.71M
Enterprise Value 46.14M

Important Dates

The last earnings date was Wednesday, September 17, 2025.

Earnings Date Sep 17, 2025
Ex-Dividend Date n/a

Share Statistics

VIE:MARI has 1.84 million shares outstanding. The number of shares has increased by 17.17% in one year.

Current Share Class 1.84M
Shares Outstanding 1.84M
Shares Change (YoY) +17.17%
Shares Change (QoQ) n/a
Owned by Insiders (%) 28.69%
Owned by Institutions (%) 25.38%
Float 1.31M

Valuation Ratios

The trailing PE ratio is 3.89 and the forward PE ratio is 1.59.

PE Ratio 3.89
Forward PE 1.59
PS Ratio 3.76
PB Ratio -6.75
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 5.06
EV / Sales 4.73
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.74

Current Ratio 0.74
Quick Ratio 0.68
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -12.75%
Return on Invested Capital (ROIC) -17.23%
Return on Capital Employed (ROCE) -53.72%
Revenue Per Employee 295,773
Profits Per Employee 276,270
Employee Count47
Asset Turnover 1.03
Inventory Turnover 7.96

Taxes

Income Tax -117,980
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +110.00% in the last 52 weeks. The beta is -0.13, so VIE:MARI's price volatility has been lower than the market average.

Beta (5Y) -0.13
52-Week Price Change +110.00%
50-Day Moving Average 20.12
200-Day Moving Average 16.50
Relative Strength Index (RSI) 50.94
Average Volume (20 Days) 707

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, VIE:MARI had revenue of EUR 9.76 million and earned 9.12 million in profits. Earnings per share was 5.13.

Revenue9.76M
Gross Profit 6.47M
Operating Income -1.93M
Pretax Income 9.00M
Net Income 9.12M
EBITDA -1.57M
EBIT -1.93M
Earnings Per Share (EPS) 5.13
Full Income Statement

Balance Sheet

The company has 1.49 million in cash and 10.92 million in debt, giving a net cash position of -9.43 million or -5.13 per share.

Cash & Cash Equivalents 1.49M
Total Debt 10.92M
Net Cash -9.43M
Net Cash Per Share -5.13
Equity (Book Value) -5.44M
Book Value Per Share -3.06
Working Capital -1.06M
Full Balance Sheet

Cash Flow

Operating Cash Flow -800,000
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 66.33%, with operating and profit margins of -19.81% and 93.41%.

Gross Margin 66.33%
Operating Margin -19.81%
Pretax Margin 92.20%
Profit Margin 93.41%
EBITDA Margin -16.09%
EBIT Margin -19.81%
FCF Margin n/a

Dividends & Yields

VIE:MARI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.17%
Shareholder Yield n/a
Earnings Yield 24.84%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

VIE:MARI has an Altman Z-Score of -7.97 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.97
Piotroski F-Score 4